Traws Pharma, Inc. — Director's Dealing 2025

Oct 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Traws Pharma, Inc. (TRAW)
CIK: 0001130598
Period of Report: 2025-10-12

Reporting Person: Pauza Charles David (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-10-12	Stock Option (right to purchase)	$3.01	A	32406	Acquired	2035-10-12	Common Stock (32406)	Direct

Footnotes

F1: The options vest 100% on the first anniversary of the grant date.